Evidence map›Paper›PMID 20005486›Full record

ReviewAdvances in chronic kidney disease2010

Screening for chronic kidney disease in HIV-infected patients.

Michelle M Estrella, Derek M Fine

Open access · bronzeAbstract readReview
In one paragraph

Review in Advances in chronic kidney disease, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. GWAS in Mice Maps Susceptibility to HIV-Associated Nephropathy to theJournal of the American Society of Nephrology : JASN · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Observational
  13. Review
  14. Review
  15. Review
  16. Review
  17. Renal dysfunction in the setting of HIV/AIDS.Current HIV/AIDS reports · 2012
    Review
  18. Review
  19. Article
  20. Related factors to atazanavir plasma levels in a cohort of HIV positive individuals with undetectable viral load.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Michelle M EstrellaJohns Hopkins School of Medicine, Baltimore, MD, USA. mestrel1@jhmi.edu
Derek M Fine
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

Burden of Chronic Kidney Disease in HIV InfectionK23DK081317 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI ESTRELLA, MICHELLE M · 2009 to 2013
$835k
NIDDK NIH HHS 1K23DK081317-01A1NIDDK NIH HHS K23 DK081317
6 · The paper itself

Abstract

With improved survival afforded by highly active antiretroviral therapy (HAART), CKD has emerged as one of the primary comorbid conditions affecting HIV-infected individuals. Although CKD in HIV-infected individuals is classically thought of as a consequence of advanced HIV infection such as in the case of HIV-associated nephropathy, several factors likely contribute to the development CKD in HIV infection. These factors include genetic predisposition, age-related decline in kidney function, HAART-related metabolic changes, exposure to multiple nephrotoxic medications, and concurrent conditions such as hepatitis C or illicit drug use. Similar to the general population, proteinuria and impaired kidney function are associated with faster progression to acquired immune deficiency syndrome and death. Given the prevalence and impact of kidney disease on the course of HIV infection and its management, current guidelines recommend screening all HIV-infected individuals for kidney disease. This review focuses on the current guidelines for kidney disease screening and discusses traditional as well as promising strategies for detecting CKD in this vulnerable population.

Indexed as

Practice Guidelines as TopicAIDS-Associated NephropathyHumansMass ScreeningPrevalenceProteinuriaRenal Insufficiency, Chronic

Identifiers

PMID20005486
PMCPMC2818858
OpenAlexW2011047846

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.